The DOI matches its Crossref record; 80 of the 80 references it cites were found in a registry or an index.
Tumor-derived spheroids: Relevance to cancer stem cells and clinical applications
Open accessAbstract
Recently, many types of in vitro 3-D culture systems have been developed to recapitulate the in vivo growth conditions of cancer. The cancer 3-D culture methods aim to preserve the biological characteristics of original tumors better than conventional 2-D monolayer cultures, and include tumor-derived organoids, tumor-derived spheroids, organotypic multicellular spheroids, and multicellular tumor spheroids. The 3-D culture methods differ in terms of cancer cell sources, protocols for cell handling, and the required time intervals. Tumor-derived spheroids are unique because they are purposed for the enrichment of cancer stem cells (CSCs) or cells with stem cell-related characteristics. These spheroids are grown as floating spheres and have been used as surrogate systems to evaluate the CSC-related characteristics of solid tumors in vitro. Because eradication of CSCs is likely to be of clinical importance due to their association with the malignant nature of cancer cells, such as tumorigenicity or chemoresistance, the investigation of tumor-derived spheroids may provide invaluable clues to fight against cancer. Spheroid cultures have been established from cancers including glioma, breast, colon, ovary, and prostate cancers, and their biological and biochemical characteristics have been investigated by many research groups. In addition to the investigation of CSCs, tumor-derived spheroids may prove to be instrumental for a high-throughput screening platform or for the cultivation of CSC-related tumor cells found in the circulation or body fluids.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“3D patient-derived tumor models of CRC (i.e., organoid and spheroid cultures) allow maintenance and expansion of functionally relevant cell subfractions and harbor the patients' individual genetic lesions (Ishiguro et al., 2017;van de Wetering et al., 2015).”
From Degradation of CCNK/CDK12 is a druggable vulnerability of colorectal cancer (2021) · cites this paper as Ishiguro et al., 2017
In the citing paper
“Moreover, TICs that have the capacity to self-renew and maintain long-term tumor growth are usually rare within the tumor mass but highly enriched within spheroid cultures (Dieter et al., 2011;Ishiguro et al., 2017).”
From Degradation of CCNK/CDK12 is a druggable vulnerability of colorectal cancer (2021) · cites this paper as Ishiguro et al., 2017
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prospective identification of tumorigenic breast cancer cells
Al‐Hajj, M., Wicha, M. S., Benito‐Hernández, A., Morrison, S. J., & Clarke, M. F. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0530291100 · Cited by 10,579
A cell initiating human acute myeloid leukaemia after transplantation into SCID mice
Lapidot, T., Sirard, C., Vormoor, J., Murdoch, B., Hoang, T., Caceres-Cortes, J., Minden, M., Paterson, B., Caligiuri, M. A., & Dick, J. E. (1994) · Nature · doi:10.1038/367645a0 · Cited by 4,783
Reynolds, B. A., & Weiss, S. (1992) · Science · doi:10.1126/science.1553558 · Cited by 4,482
Identification and expansion of human colon-cancer-initiating cells
Ricci‐Vitiani, L., Lombardi, D. G., Pilozzi, E., Biffoni, M., Todaro, M., Peschle, C., & Maria, R. D. (2006) · Nature · doi:10.1038/nature05384 · Cited by 4,001
Sato, T., Stange, D. E., Ferrante, M., Vries, R. G. J., van Es, J. H., van den Brink, S., van Houdt, W. J., Pronk, A., van Gorp, J., Siersema, P. D., et al. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.07.050 · Cited by 3,753
Modeling Development and Disease with Organoids
Clevers, H. (2016) · Cell · doi:10.1016/j.cell.2016.05.082 · Cited by 3,196
Clarke, M. F., Dick, J. E., Dirks, P. B., Eaves, C., Jamieson, C., Jones, D. L., Visvader, J., Weissman, I. L., & Wahl, G. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-3126 · Cited by 3,124
The third dimension bridges the gap between cell culture and live tissue
Pampaloni, F., Reynaud, E. G., & Stelzer, E. H. K. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2236 · Cited by 2,817
In vitro propagation and transcriptional profiling of human mammary stem/progenitor cellsPreprint
Dontu, G., Abdallah, W. M., Foley, J. M., Jackson, K. W., Clarke, M. F., Kawamura, M., & Wicha, M. S. (2003) · Genes & Development · doi:10.1101/gad.1061803 · Cited by 2,413
Lee, J., Kotliarova, S. E., Kotliarov, Y., Li, A., Su, Q., Donin, N. M., Pastorino, S., Purow, B. W., Christopher, N., Zhang, W., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.03.030 · Cited by 2,345
Flagged first, then by citations
Cited by
Sorted by citations
Items 301–400 of 530
Ohata, H., Shiokawa, D., Sakai, H., Kanda, Y., Okimoto, Y., Kaneko, S., Hamamoto, R., Nakagama, H., & Okamoto, K. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112519 · Cited by 7
Kumar, M., Nassour-Caswell, L. C., Alrefai, H., Anderson, J. C., Schanel, T. L., Hicks, P. H., Cardan, R., & Willey, C. D. (2024) · Cells · doi:10.3390/cells13231995 · Cited by 7
Sanchez‐Maldonado, B., Galicia, M. D. L., Rojo, C., Gil, A. G., Flor‐García, M., & Picazo, R. A. (2018) · Stem Cells and Development · doi:10.1089/scd.2017.0141 · Cited by 7
Yani, M. V. W., Anjani, I. A. W., Narayana, I. G. S., Wihandani, D. M., & Supadmanaba, I. G. P. (2020) · Journal Of Medicine & Health · doi:10.28932/jmh.v2i5.1129 · Cited by 7
Contartese, D., Salamanna, F., Veronesi, F., & Fini, M. (2020) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-020-03513-y · Cited by 7
Granger, C. J., Hoyt, A. K., Moran, A., Becker, B. C., Sedani, A. B., Saigh, S. J., Conway, S. A., Brown, J., & Galoian, K. A. (2020) · Molecular Medicine Reports · doi:10.3892/mmr.2020.11480 · Cited by 8
Zhao, M., Li, X., & Chen, X. (2021) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-021-09875-7 · Cited by 9
Assessment of Breast Cancer Stem Cell Activity Using a Spheroid Formation Assay
Nandi, A., & Chakrabarti, R. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-1979-7_33 · Cited by 8
Lipp, C., Koebel, L., Bertsch, A., Gauthier, M., Bolopion, A., & Renaud, P. (2022) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2022.910578 · Cited by 9
RELA is required for CD271 expression and stem-like characteristics in hypopharyngeal cancer
Nakazato, A., Mochizuki, M., Shibuya‐Takahashi, R., Fujimori, H., Fujii, K., Saijoh, S., Morita, S., Yamazaki, T., Imai, T., Sato, I., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-22736-6 · Cited by 7
The generation of glioma organoids and the comparison of two culture methods
Zhang, Y., Shao, Y., Li, Y., Li, X., Zhang, X., Qinzhi, E., Wang, W., Jiang, Z., Gan, W., & Huang, Y. (2024) · Cancer Medicine · doi:10.1002/cam4.7081 · Cited by 7
Study on Adenovirus Infection in vitro with Nanoself-Assembling Peptide as Scaffolds for 3D Culture
Ao, D.-S., Gao, L.-Y., Gu, J.-H., Qiao, J.-H., Wang, H., Liu, Y., & Song, H. (2020) · International Journal of Nanomedicine · doi:10.2147/ijn.s239395 · Cited by 7
A Novel 3D Culture Scaffold to Shorten Development Time for Multicellular Tumor Spheroids
Yang, C.-R., Liang, C.-T., Tsai, S.-C., Wu, Y.-C., Liu, C.-W., Yang, H., Tu, T., Lee, Y., Hsiao, K., Chang, W., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232213962 · Cited by 6
Recent advances in lung cancer organoid (tumoroid) research (Review)
Zhang, Q., & Zhang, M. (2024) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2024.12672 · Cited by 8
Kudo, K., Greer, Y. E., Crooks, D. R., Yang, Y., Brender, J., Yoshida, T., Harrington, B. S., Kamdar, R. D., Korrapati, S., Shibuya, Y., et al. (2025) · Cell Death and Disease · doi:10.1038/s41419-025-07672-3 · Cited by 7
Rial, R., Guimarães, C. F., Gasperini, L., Brito, A., Costa, R. R., Ruso, J. M., & Reis, R. L. (2025) · Matter · doi:10.1016/j.matt.2025.102196 · Cited by 6
Mastering Organoid Growth: A Complete Guide to Overcoming Methodological Challenges
Jiao, C., Karakaya, O. F., Dadgar, N., Wehrle, C. J., Massoud, Z., Hong, H., Fairchild, R. L., Leipzig, N. D., Aucejo, F., Ma, W. W., et al. (2026) · MedComm · doi:10.1002/mco2.70571 · Cited by 9
Jasim, S. A., Salahdin, O. D., Malathi, H., Sharma, N., Rab, S. O., Aminov, Z., Pramanik, A., Mohammed, I. H., Jawad, M. A., & Gabel, B. C. (2024) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-024-01423-5 · Cited by 6
Delta‐6 desaturase FADS2 is a tumor‐promoting factor in cholangiocarcinoma
Hasegawa, K., Fujimori, H., Nakatani, K., Takahashi, M., Izumi, Y., Bamba, T., Nakamura, M., Shibuya‐Takahashi, R., Mochizuki, M., Wakui, Y., et al. (2024) · Cancer Science · doi:10.1111/cas.16306 · Cited by 5
Grandits, A. M., Bromberger, S., Heller, G., Reinoehl, B. A., Tomasich, E., Schossleitner, K., Berghoff, A. S., Fuereder, T., & Wieser, R. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031050 · Cited by 6
Murad, H. Y., Chandra, P. K., Kelly, C. A., Khurana, N., Yu, H., Bortz, E., Hong, S. N., Mondal, D., & Khismatullin, D. B. (2022) · Antioxidants · doi:10.3390/antiox11020341 · Cited by 6
Kim, M. S., Lee, W. S., Park, Y., & Jin, W. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-05298-3 · Cited by 6
Modelling cutaneous squamous cell carcinoma for laboratory research
Kumah, E., & Bibee, K. (2022) · Experimental Dermatology · doi:10.1111/exd.14706 · Cited by 6
AhRR and PPP1R3C: Potential Prognostic Biomarkers for Serous Ovarian Cancer
Ardizzoia, A., Jemma, A., Redaelli, S., Silva, M., Bentivegna, A., Lavitrano, M., & Conconi, D. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241411455 · Cited by 6
Jeon, H., Zanon, T. T. M., Carpenter, J., Ilias, A., Colón, Y. J., & Wang, Y. (2025) · Small Science · doi:10.1002/smsc.202400440 · Cited by 6
Rentzeperis, F., & Wallace, D. I. (2022) · Applied Mathematical Modelling · doi:10.1016/j.apm.2022.05.006 · Cited by 7
Breast Organotypic Cancer Models
Carranza‐Rosales, P., Guzmán‐Delgado, N. E., Torres, I. E. C., Viveros‐Valdez, E., & Morán‐Martínez, J. (2018) · Current topics in microbiology and immunology · doi:10.1007/82_2018_86 · Cited by 6
Truong, T. T., Park, H.-J., Park, K. H., Song, J. J., Lee, B., Huh, K. M., & Kang, S. (2024) · Biomaterials Research · doi:10.34133/bmr.0018 · Cited by 6
Ruan, H.-X., Fang, Y.-L., Qin, X.-N., & Lin, L. (2025) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v17.i8.108535 · Cited by 5
Gajón, J. A., Juárez-Flores, Á., Mendoza-Roldan, F., Hernández-Aceves, J. A., Muñoz-Cruz, S., Pérez‐Torres, A., Fuentes‐Pananá, E. M., & Bonifaz, L. C. (2025) · OncoImmunology · doi:10.1080/2162402x.2025.2595360 · Cited by 5
Sasagawa, S., Kumai, J., Wakamatsu, T., & Yui, Y. (2024) · Cancer Innovation · doi:10.1002/cai2.113 · Cited by 5
Ueda, H., Ishiguro, T., Mori, Y., Yamawaki, K., Okamoto, K., Enomoto, T., & Yoshihara, K. (2024) · Cell Death Discovery · doi:10.1038/s41420-024-02204-y · Cited by 5
Beyond the brain: Reelin's emerging role in cancer pathways
Hsu, C., Ismaeel, G. L., Kadhim, O., Hadi, Z. D., Alubiady, M. H. S., Alasheqi, M. Q., Ali, M. S., Ramadan, M. F., Al‐Abdeen, S. H. Z., Muzammil, K., et al. (2025) · Pathology - Research and Practice · doi:10.1016/j.prp.2025.155901 · Cited by 5
Koshkin, V., de Oliveira, M. B., Peng, C., Ailles, L., Liu, G., Covens, A. L., & Krylov, S. N. (2020) · Analytical Chemistry · doi:10.1021/acs.analchem.0c01667 · Cited by 5
Kerns, S. J., Belgur, C., Kanellias, M., Manatakis, D. V., Petropolis, D., Barrile, R., Tien-Street, W., Ewart, L. C., Gjorevski, N., & Cabon, L. (2023) · BIO-PROTOCOL · doi:10.21769/bioprotoc.4579 · Cited by 5
Saha, M., & Ghosh, S. S. (2023) · ACS Applied Bio Materials · doi:10.1021/acsabm.2c00925 · Cited by 5
Phospholipid‐Coated Boronic Oxide Nanoparticles as Boron Agents for Boron Neutron Capture Therapy
Kawasaki, R., Hirano, H., Yamana, K., Oshige, A., Nishimura, K., Kono, N., Sanada, Y., Bando, K., Tabata, A., Yasukawa, N., et al. (2023) · ChemBioChem · doi:10.1002/cbic.202300186 · Cited by 5
SOX2 Expression Does Not Guarantee Cancer Stem Cell-like Characteristics in Lung Adenocarcinoma
Bae, S.-H., Lee, K. Y., Han, S., Yun, C. W., Park, C., & Jang, H. (2024) · Cells · doi:10.3390/cells13030216 · Cited by 5
Proteomic study on nintedanib in gastric cancer cells
Dong, X., Wang, L., Wang, D., Yu, M., Yang, X. J., & Cai, H. (2024) · PeerJ · doi:10.7717/peerj.16771 · Cited by 5
Mochizuki, M., Shibuya‐Takahashi, R., Kanno, S.-I., Adachi, S., Fujimori, H., Nakazato, A., Fujii, K., Morita, S., Saijoh, S., Yamazaki, T., et al. (2024) · Cancer Science · doi:10.1111/cas.16187 · Cited by 4
Wang, H., Lu, J. L., Chen, K., Ma, B., Henchy, C., Knapp, J., Ranganathan, S., & Prochownik, E. V. (2025) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2025.152478 · Cited by 5
Fujibayashi, E., Yabuta, N., Nishikawa, Y., Uchihashi, T., Miura, D., Kurioka, K., Tanaka, S., Kogo, M., & Nojima, H. (2018) · Oncotarget · doi:10.18632/oncotarget.26092 · Cited by 5
Kobyakova, M. I., Евстратова, Я. В., Сенотов, А. С., Lomovsky, A. I., Minaichev, V., Zvyagina, A. I., Solovieva, M. E., Fadeeva, I. S., Акатов, В. С., & Фадеев, Р. С. (2021) · Biochemistry (Moscow) Supplement Series A Membrane and Cell Biology · doi:10.1134/s1990747821010050 · Cited by 5
Establishment of in vitro 3D spheroid cell cultivation from human gynecologic cancer tissues
Ueda, H., Mori, Y., Yamawaki, K., Ishiguro, T., Ohata, H., Sato, A., Sugino, K., Yachida, N., Yamaguchi, M., Suda, K., et al. (2021) · STAR Protocols · doi:10.1016/j.xpro.2021.100354 · Cited by 5
New Born Calf Serum Can Induce Spheroid Formation in Breast Cancer KAIMRC1 Cell Line
Ali, R., Huwaizi, S. M., Alhallaj, A., Subait, A. A., Barhoumi, T., Zahrani, H. A., Anazi, A. A., Khan, A. L., & Boudjelal, M. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.769030 · Cited by 6
Evaluation of the Effectiveness of Various Autophagy Inhibitors in A549 Cancer Stem Cells
Aleksandrova, K. V., & Suvorova, I. I. (2023) · Acta Naturae · doi:10.32607/actanaturae.11891 · Cited by 5
A promising breakthrough in pancreatic cancer research: The potential of spheroids as 3D models
Jamshidi, N., Jamshidi, N., Chahardehi, A. M., Shams, E., & Chaleshi, V. (2024) · Bioimpacts · doi:10.34172/bi.30241 · Cited by 4
Upadhyay, V., Das, S., Nehru, A., Swetha, U. S., Vatsa, P. P., Chamoli, A., & Mandoli, A. (2025) · 3 Biotech · doi:10.1007/s13205-025-04472-6 · Cited by 4
Maiti, A., Axtman, A. D., Wu, R., Redman, L. J. B., Takabe, K., Stablewski, A. B., Yan, L., Ciesielski, M. J., Zhang, J., Evans, S. S., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-24354-4 · Cited by 4
Natural compound-nanoparticle therapies for breast cancer: A review from 2018-2025
Zhang, X., Gao, F., Sun, X., Ganesan, K., & Chen, J. (2025) · Phytomedicine · doi:10.1016/j.phymed.2025.157652 · Cited by 6
Özateş, N. P., Bağca, B. G., Aşık, A., Gündüz, C., Akin, H., & Avci, Ç. B. (2026) · Scientific Reports · doi:10.1038/s41598-025-30686-y · Cited by 5
Sato, S., Nakayama, K., Kanno, K., Sultana, R., Ishikawa, M., Ishibashi, T., Yamashita, H., & Kyo, S. (2023) · Cancer Science · doi:10.1111/cas.15767 · Cited by 4
BEX2 is poor prognostic factor and required for cancer stemness in gastric cancer
Yasumoto, A., Fujimori, H., Mochizuki, M., Shibuya‐Takahashi, R., Nakamura, M., Shindo, N., Yamaguchi, K., Fukushi, D., Wakui, Y., Sugai, T., et al. (2023) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2023.03.025 · Cited by 4
Yoon, C., Lu, J., Jun, Y., Suh, Y., Kim, B., Till, J. E., Kim, J. H., Keshavjee, S., Ryeom, S. W., & Yoon, S. S. (2023) · BMC Cancer · doi:10.1186/s12885-023-11170-0 · Cited by 4
RetractedDUX4-r exerts a neomorphic activity that depends on GTF2I in acute lymphoblastic leukemia
Campolungo, D., Salomè, M., Biferali, B., Tascini, A. S., & Gabellini, D. (2023) · Science Advances · doi:10.1126/sciadv.adi3771 · Cited by 4
The role of hypoxia and radiation in developing a CTCs-like phenotype in murine osteosarcoma cells
Quartieri, M., Puspitasari, A., Vitacchio, T., Durante, M., & Tinganelli, W. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1222809 · Cited by 5
Jung, Y. H., Kim, I. K., Eom, S. Y., Kim, H., Park, K., Chung, S. H., Lee, S. H., Yeo, C. D., Kim, H. J., & Kang, H. S. (2024) · Molecular & Cellular Toxicology · doi:10.1007/s13273-024-00435-9 · Cited by 4
Kumar, P., Yadav, U. P., Joshi, G., Arora, S., Kumar, M., Chatterjee, J., Chandra, V., Singh, S., Kumar, R., & Kumar, S. (2024) · ChemistrySelect · doi:10.1002/slct.202400223 · Cited by 4
Moreira, M. P., Franco, E. P., Barros, B. A. F., Anjos, B. R. D., Almada, D. D. G., Barbosa, I. N. T., Braga, L. D. C., Cassali, G. D., & Silva, L. M. (2024) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2024.150765 · Cited by 4
Hoang, V. H., Hương, L. T., Nguyen, P. H., Nguyen, D. H., Luc, Q. T., Nguyen, T. K. O., & Do, K. H. (2025) · Beni-Suef University Journal of Basic and Applied Sciences · doi:10.1186/s43088-025-00634-w · Cited by 4
Modelos tridimensionais de cultura de células: aproximando o in vitro do in vivo
Cavalheiro, M., de Barros, A. P. D. N., Louback, R. D. A., & Rossi, M. I. D. (2018) · Vigilância Sanitária em Debate · doi:10.22239/2317-269x.01047 · Cited by 7
Pommergaard, H., Rasmussen, A., Hillingsø, J., & Kugler, J. (2021) · Surgical Oncology · doi:10.1016/j.suronc.2021.101677 · Cited by 4
Smart delivery of poly-peptide composite for effective cancer therapy
Yuan, X., Qin, Y., Tian, Q., Liu, C., Meng, X., Qie, B., Gao, F., Huang, Y., Xu, G., Yang, G., et al. (2022) · Biomedical Materials · doi:10.1088/1748-605x/ac494c · Cited by 4
Meneghetti, B. V., Wilson, R., Dias, C. K., Cadore, N. A., Klamt, F., Zaha, A., Ferreira, H. B., & Monteiro, K. M. (2022) · Biochimie · doi:10.1016/j.biochi.2022.03.003 · Cited by 5
Baron, C., Buchholz, M., Majchrzak‐Stiller, B., Peters, I., Fein, D., Müller, T. H., Uhl, W., Höhn, P., Strotmann, J., & Braumann, C. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23137293 · Cited by 4
Han, C.-H., Ma, J., Zou, W., Qu, J., Du, Y., Li, N., Liu, Y., Guo, J., Leng, A., & Liu, J. (2022) · Chinese Journal of Integrative Medicine · doi:10.1007/s11655-021-3726-1 · Cited by 4
Biomechanical Response of Cancer Stem Cells to Low-Intensity Ultrasound
Yang, Y., Du, M., Yu, J., & Chen, Z. (2023) · Journal of Biomechanical Engineering · doi:10.1115/1.4062299 · Cited by 4
SMYD3 Modulates the HGF/MET Signaling Pathway in Gastric Cancer
Marco, K. D., Signorile, M. L., Nicola, E. D., Sanese, P., Fasano, C., Forte, G., Disciglio, V., Pantaleo, A., Varchi, G., Río, A. D., et al. (2023) · Cells · doi:10.3390/cells12202481 · Cited by 4
Lin, Y., Lin, Y., & Liang, C. (2023) · Cytopathology · doi:10.1111/cyt.13321 · Cited by 4
Sphéroïdes : le modèle de référence pour la culture in vitro des tumeurs solides ?
Larsen, C. (2017) · Bulletin du Cancer · doi:10.1016/j.bulcan.2017.09.008 · Cited by 4
Mohapatra, S., Das, G., Gupta, V., Mondal, P., Nitani, M., Ie, Y., Chatterjee, S., Aso, Y., & Ghosh, S. (2021) · ACS Omega · doi:10.1021/acsomega.1c00308 · Cited by 4
An Omentum-inspired 3D PEG Hydrogel for Identifying ECM-drivers of Drug Resistant Ovarian CancerPreprint
Brooks, E. A., Gencoglu, M. F., Corbett, D. C., Stevens, K. R., & Peyton, S. R. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/560482 · Cited by 4
Sirenko, O., Brock, C. K., Lim, A. P. C., Macha, P., Nikolov, E., Olsen, C., McConnell, E. C., Wright, M. K., Collins‐Burow, B. M., Cromwell, E. F., et al. (2022) · Research Square · doi:10.21203/rs.3.rs-1859525/v1 · Cited by 4
Jemma, A., Ardizzoia, A., Villa, C., Bonomo, S., Mauri, M., Reale, C., Ambrosino, C., Cadamuro, M., Lavitrano, M., & Conconi, D. (2025) · Cancers · doi:10.3390/cancers17101605 · Cited by 3
Yang, M. H., Ma, Y., Cao, Z., Zhan, H., Jin, Y., Huang, X., & Yang, S. (2025) · Biochemical Genetics · doi:10.1007/s10528-025-11144-w · Cited by 3
Monitoring and modulation of the tumor microenvironment for enhanced cancer modeling
Head, T., & Cady, N. C. (2022) · Experimental Biology and Medicine · doi:10.1177/15353702221074293 · Cited by 3
Progressing Towards a Human-Centric Approach in Cancer Research
Parekh, A., Das, S., Das, C. K., & Mandal, M. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.896633 · Cited by 4
Mazzoccoli, C., Crispo, F., Laurenzana, I., Pietrafesa, M., Sisinni, L., Lerose, R., Telesca, D., Milella, M. R., Liu, T., Sala, G. D., et al. (2023) · Archiv der Pharmazie · doi:10.1002/ardp.202300354 · Cited by 3
Implicating the cholecystokinin B receptor in liver stem cell oncogenesis
Gay, M. D., Drda, J. C., Chen, W., Huang, Y., Yassin, A. A., Duka, T., Fang, H., Shivapurkar, N., & Smith, J. P. (2024) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00208.2023 · Cited by 3
MicroRNA-135b mainly functions as an oncogene during tumor progression
Ghasaban, F. T., Taghehchian, N., Zangouei, A. S., Keivany, M. R., & Moghbeli, M. (2024) · Pathology - Research and Practice · doi:10.1016/j.prp.2024.155547 · Cited by 4
Next-Generation models of Gallbladder Carcinoma: Linking biological insights to precision medicine
Sahoo, O. S., Minocha, R., Kumar, D., Nayek, A., Singh, G., Bhardwaj, N., Sarkar, S. K., Nayak, N. R., Dhar, R., & Karmakar, S. (2025) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2025.104827 · Cited by 5
Comparison of two- and three-dimensional cancer models for assessing potential cancer therapeutics
Xie, B., Teusch, N. E., & Mrsny, R. J. (2020) · Elsevier eBooks · doi:10.1016/b978-0-08-102983-1.00014-4 · Cited by 3
Visualizing the cancer stem‐like properties of canine tumour cells with low proteasome activity
Sung, K., Hosoya, K., Murase, Y., Deguchi, T., Kim, S., SUNAGA, T., & Okumura, M. (2021) · Veterinary and Comparative Oncology · doi:10.1111/vco.12779 · Cited by 3
Freeburg, N. F., Peterson, N., Ruiz, D. A., Gladstein, A. C., & Feldser, D. M. (2023) · Cancer Research Communications · doi:10.1158/2767-9764.crc-23-0172 · Cited by 4
CD271 promotes proliferation and migration in bladder cancer
Myoen, S., Mochizuki, M., Shibuya‐Takahashi, R., Fujimori, H., Shindo, N., Yamaguchi, K., Yasuda, J., Abe, J., Imai, T., Sato, I., et al. (2023) · Genes to Cells · doi:10.1111/gtc.13087 · Cited by 3
Todorov, T. Z., Schibli, R., Béhé, M. P., & Grünberg, J. (2024) · International Journal of Translational Medicine · doi:10.3390/ijtm4030031 · Cited by 3
Skin squamous cell carcinoma models: The role in combating the disease
Loriè, E. P., Stark, H., Berning, M., & Boukamp, P. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-810545-0.00007-3 · Cited by 3
Kanda, Y., Ohata, H., Miyazaki, T., Sakai, H., Mori, Y., Shiokawa, D., Yokoi, A., Owa, T., Ochiai, A., & Okamoto, K. (2021) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2021.11.063 · Cited by 3
Luján, E., Soto, D., Rosito, M. S., Soba, A., Guerra, L. N., Calvo, J. C., Marshall, G., & Suárez, C. A. (2018) · Integrative Biology · doi:10.1039/c8ib00049b · Cited by 3
Balahmar, R. M., Deepak, V., & Sivasubramaniam, S. D. (2022) · 3 Biotech · doi:10.1007/s13205-022-03243-x · Cited by 3
Evaluation of Anticancer Effects of Curcumin on Multicellular Breast Cancer Spheroids
Kamalabadi‐Farahani, M. (2022) · Turkish Journal of Oncology · doi:10.5505/tjo.2022.3512 · Cited by 3
de Oliveira, L. M., de Lima, L. V. A., da Silva, M. F., Felicidade, I., Lepri, S. R., & Mantovani, M. S. (2023) · Journal of Toxicology and Environmental Health · doi:10.1080/15287394.2023.2255886 · Cited by 3
Role of Sam68 in different types of cancer (Review)
Jiménez‐Cortegana, C., Sánchez-Jiménez, F., de la Cruz‐Merino, L., & Sánchez‐Margalet, V. (2024) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2024.5444 · Cited by 2
ECT2+ cell group acts as cancer stem cell in malignant pleomorphic adenoma
Chen, W., Wang, Y., Yao, Z., Gu, T., Hu, Y., Leng, N.-N., Zhang, C., Tian, Z., & Jiang, L. (2025) · npj Precision Oncology · doi:10.1038/s41698-025-00974-x · Cited by 2
3D bioprinting innovations: a new frontier in breast cancer research
Seifi, Z., Khazaei, M., Dayani, M., Zamani, S., Abdalla, S. B., & Rezakhani, L. (2025) · Medical Oncology · doi:10.1007/s12032-025-03069-6 · Cited by 3
Hepatoblastoma Cell Lines: Past, Present and Future
Prochownik, E. V., Henchy, C., & Wang, H. (2025) · Cells · doi:10.3390/cells14242013 · Cited by 2
Advancing the Study of Glioblastoma Through 3D Tumor Models
Salmeron-Moreno, K., Buclez, J., Kim, C. D., Papisetty, K., McCaffery, T. D., Jacob, F., Kashlan, R., Duggireddy, H., Valiveti, K., Maldonado, J., et al. (2026) · Cancers · doi:10.3390/cancers18040668 · Cited by 2
Organoid Models of the Oral Mucosa for Precision Medicine
Atwa, A., Wadan, A. S., Hallool, S. I., Shati, A. A., Elbehairi, S. E. I., Alfaifi, M. Y., & Hussein, A. M. (2026) · Tissue Engineering Part B Reviews · doi:10.1177/19373368261420588 · Cited by 3
Salinomycin as a death switch: how gastric cancer cells choose their demise
Laurenziello, P., Luongo, M., Severini, F. L., Calice, G., Bartolo, O., Falco, G., Calabrese, C., Russi, S., & Laurino, S. (2026) · Cell Death Discovery · doi:10.1038/s41420-026-03058-2 · Cited by 2
Ryu, S., Yoon, S.-H., Song, J., Choi, Y., Lee, S. E., Baek, M., Lee, H., Jeon, S. Y., Jon, S., Lee, D., et al. (2023) · BMC Cancer · doi:10.1186/s12885-023-11185-7 · Cited by 2
Metadata
- Authors
- Ishiguro, T., Ohata, H., Sato, A., Yamawaki, K., Enomoto, T., & Okamoto, K.
- Affiliations
- Niigata University (JP)
- National Cancer Center Research Institute (JP)
- Corresponding author
- Okamoto, Koji
- Venue
- Cancer Science
- Publisher
- Wiley
- Published
- 2017-03
- Volume
- 108
- Issue
- 3
- Pages
- 283-289
- ISSN
- 1347-9032 (ISSN-L)
- 1349-7006
- PMC
- PMC5378268
- OpenAlex
- W2570959155
- Cited by
- 530
- References
- 80
- Citations by year
- 2026: 35 · 2025: 59 · 2024: 67 · 2023: 69 · 2022: 64 · 2021: 65 · 2020: 70 · 2019: 55 · 2018: 33 · 2017: 11
- FWCI
- 4.85
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Cancer Science (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Institutional Repositories DataBase (IRDB) (submittedVersion)
- Funders
- Ministry of Education, Culture, Sports, Science and Technology
- National Cancer Center
- Japan Society for the Promotion of Science
- Japan Agency for Medical Research and Development
- Topics
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Physical Sciences › Engineering › Biomedical Engineering › 3D Printing in Biomedical Research
- Physical Sciences › Mathematics › Modeling and Simulation › Mathematical Biology Tumor Growth
- Keywords
- cancer stem cells, tumor spheroids, tumor organoids, chemoresistance, tumorigenicity, high-throughput screening, circulating tumor cells, glioma, breast cancer, colon cancer, ovarian cancer, prostate cancer
- MeSH terms
- Humans, Neoplasms, Tumor Cells, Cultured, Neoplastic Stem Cells, Spheroids, Cellular, Cell Culture Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
